# Sermonix Pharmaceuticals, Inc.: Form D filings

Sermonix Pharmaceuticals, Inc., a pharmaceuticals company in Columbus, OH, filed 3 Form D notices with the SEC between 2015 and 2021. The latest, on November 23, 2021, reports $40.2 million sold of a $40.2 million offering to 9 investors.

Find out what Sermonix Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Sermonix%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Sermonix%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsermonix-pharmaceuticals-inc-1655566)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Sermonix%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Sermonix%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsermonix-pharmaceuticals-inc-1655566)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Ohio](https://specstream.ai/data/form-d/state/ohio): 1,071 rows, by operating companies, filed since November 1, 2024, $53.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/ohio
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3000 E. MAIN ST, Columbus, OH, 43209
- Phone: (614) 864-4919
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1655566

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 23, 2021 | New notice | $40,225,000 | $40,225,000 | $0 | 9 | Nov 12, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1655566/000165556621000002/0001655566-21-000002-index.htm) |
| Jul 11, 2016 | New notice | $2,500,000 | $1,550,000 | $950,000 | 2 | Jul 5, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1655566/000165556616000003/0001655566-16-000003-index.htm) |
| Oct 14, 2015 | New notice | $3,000,000 | $1,020,000 | $1,980,000 | 17 | Sep 28, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1655566/000165556615000002/0001655566-15-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Anthony Wild | Executive Officer, Director |  |
| Miriam Portman | Executive Officer, Promoter |  |
| Elizabeth Attias | Executive Officer |  |
| Michael Friedman | Director |  |
| Simon Jenkins | Executive Officer |  |
| Elizabeth Garner | Director |  |
| David Portman | Executive Officer, Director, Promoter |  |
| Richard De Schutter | Director |  |
| Barry Komm | Executive Officer |  |
| Thomas Pfisterer | Director |  |
| Paul Plourde | Executive Officer |  |

## Other pharmaceuticals companies in Ohio that filed recently

- [EIKONOKLASTES THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/eikonoklastes-therapeutics-inc-1805698) $16.1 million · Oct 6, 2026

[Every Form D from the week of Nov 22, 2021](https://specstream.ai/data/form-d/week/2021-11-22) · [All recent filings in Ohio](https://specstream.ai/data/form-d/state/ohio) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Sermonix Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).